Back to today’s briefing

Story perspectives

New Leukemia Drug Offers 97% Success Rate for Kids

7/17/2025

50 9

Summary

Story summary

A groundbreaking leukemia drug, blinatumomab, shines a beacon of hope for young patients like 4-year-old Madi Seivert from Iowa. With an impressive success rate of 96-97%, it dramatically lowers relapse rates and has become the go-to treatment for B-cell acute lymphoblastic leukemia. Doctors are optimistic that this could pave the way for a potential cure.

1 of 1

Story summary

A groundbreaking leukemia drug, blinatumomab, shines a beacon of hope for young patients like 4-year-old Madi Seivert from Iowa. With an impressive success rate of 96-97%, it dramatically lowers relapse rates and has become the go-to treatment for B-cell acute lymphoblastic leukemia. Doctors are optimistic that this could pave the way for a potential cure.